These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8862129)

  • 1. Stereoselective inhibition of natural killer activity by the sigma ligand (+)-pentazocine.
    Maity R; Mukherjee R; Skolnick P
    J Neuroimmunol; 1996 Oct; 70(1):7-13. PubMed ID: 8862129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
    Couture S; Debonnel G
    Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory properties of (+)-pentazocine and sigma ligands.
    Carr DJ; Mayo S; Woolley TW; DeCosta BR
    Immunology; 1992 Dec; 77(4):527-31. PubMed ID: 1493925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.
    Bergeron R; Debonnel G
    Psychopharmacology (Berl); 1997 Feb; 129(3):215-24. PubMed ID: 9084059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of sigma receptor ligands and their effects on muscarine-induced Ca(2+) changes in SH-SY5Y cells.
    Hong W; Werling LL
    Eur J Pharmacol; 2002 Feb; 436(1-2):35-45. PubMed ID: 11834244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
    Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL
    Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH-SY5Y cells as a model for sigma receptor regulation of potassium-stimulated dopamine release.
    Ault DT; Werling LL
    Brain Res; 2000 Sep; 877(2):354-60. PubMed ID: 10986350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma receptor regulation of norepinephrine release from rat hippocampal slices.
    Gonzalez-Alvear GM; Werling LL
    Brain Res; 1995 Feb; 673(1):61-9. PubMed ID: 7757480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antagonism of opioid analgesia by a sigma system.
    Chien CC; Pasternak GW
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1583-90. PubMed ID: 7996472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple pathways of sigma(1) receptor ligand uptakes into primary cultured neuronal cells.
    Yamamoto H; Karasawa J; Sagi N; Takahashi S; Horikomi K; Okuyama S; Nukada T; Sora I; Yamamoto T
    Eur J Pharmacol; 2001 Aug; 425(1):1-9. PubMed ID: 11672569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.
    Akhter N; Shiba K; Ogawa K; Kinuya S; Nakajima K; Mori H
    Nucl Med Biol; 2007 Aug; 34(6):697-702. PubMed ID: 17707810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of sigma-receptors in the increase in contraction of mouse vas deferens induced by exogenous ATP.
    Matsuno K; Kobayashi T; Mita S
    J Pharm Pharmacol; 1996 Jan; 48(1):96-9. PubMed ID: 8722504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
    Matsumoto RR; Bowen WD; de Costa BR; Houk JC
    Brain Res Bull; 1999 Mar; 48(5):497-508. PubMed ID: 10372510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sigma-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs.
    Soriani O; Le Foll F; Galas L; Roman F; Vaudry H; Cazin L
    Am J Physiol; 1999 Jul; 277(1):E73-80. PubMed ID: 10409130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand.
    Dun Y; Thangaraju M; Prasad P; Ganapathy V; Smith SB
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4785-94. PubMed ID: 17898305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites.
    Matsumoto RR; Bowen WD; Walker JM; Patrick SL; Zambon AC; Vo VN; Truong DD; De Costa BR; Rice KC
    Eur J Pharmacol; 1996 Apr; 301(1-3):31-40. PubMed ID: 8773444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), sigma (sigma) ligands, on micturition in anaesthetized rats.
    Shimizu I; Kawashima K; Ishii D; Oka M
    Br J Pharmacol; 2000 Oct; 131(3):610-6. PubMed ID: 11015314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
    Ault DT; Werling LL
    Brain Res; 1997 Jun; 760(1-2):210-7. PubMed ID: 9237537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.